venBio Partners’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,759,791
| Closed | -$341K | – | 7 |
|
|
2023
Q4 | $341K | Hold |
2,759,791
| – | – | 0.05% | 7 |
|
|
2023
Q3 | $1.19M | Hold |
2,759,791
| – | – | 0.34% | 8 |
|
|
2023
Q2 | $3.5M | Hold |
2,759,791
| – | – | 1.27% | 7 |
|
|
2023
Q1 | $3.86M | Hold |
2,759,791
| – | – | 2.14% | 5 |
|
|
2022
Q4 | $10.3M | Hold |
2,759,791
| – | – | 3.21% | 5 |
|
|
2022
Q3 | $13.4M | Hold |
2,759,791
| – | – | 3.11% | 7 |
|
|
2022
Q2 | $25.7M | Hold |
2,759,791
| – | – | 7.32% | 6 |
|
|
2022
Q1 | $17.6M | Hold |
2,759,791
| – | – | 3.9% | 7 |
|
|
2021
Q4 | $23.8M | Hold |
2,759,791
| – | – | 4.29% | 6 |
|
|
2021
Q3 | $33.6M | Hold |
2,759,791
| – | – | 3.35% | 5 |
|
|
2021
Q2 | $24.4M | Buy |
+2,759,791
| New | +$24.4M | 2.88% | 7 |
|